News Zoll agrees $538m deal to buy sleep apnoea specialist Itamar Itamar Medical was on the acquisition trail itself earlier this year, buying Spry Health to extend its sleep sensor technology range.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.